Brief: Karolinska Development Announces Boost Pharma's New Long-Term Data
Oct 31 (Reuters) - Karolinska Development AB KDEV.ST: ANNOUNCES BOOST PHARMA'S NEW LONG-TERM DATA BOOSTB4 TRIAL SHOWS OVER 50% PATIENTS FRACTURE-FREE IN SECOND YEAR Source text: ID:nGNE9KnRVg Further company coverage: KDEV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue